Etiology of Cortical and White Matter Lesions in Cyclosporin-A and FK-506 Neurotoxicity

References

1. ↵
   Joss DV, Barrett AJ, Kendra JR, Lucas CF, Desai S. Hypertension and convulsions in children receiving cyclosporin A. Lancet 1982;1:906
2. ↵
   Boogaerts MA, Zachee P, Verwilghen RL. Cyclosporin, methylprednisolone, and convulsions. Lancet 1982;2:1216-1217
3. ↵
   Dieperink H, Moller J. Ketoconazole and cyclosporin. Lancet 1982;2:1217
4. ↵
   Durrant S, Chipping PM, Palmer S, Gordon-Smith EC. Cyclosporin A, methylprednisolone, and convulsions. Lancet 1982;2:829-830
5. ↵
   Noll RB, Kulkarni R. Complex visual hallucinations and cyclosporine. Arch Neurol 1984;41:329-330

   CrossRefPubMedWeb of Science
6. Shah D, Rylance PB, Rogerson ME, Bewick M, Parsons V. Generalized epileptic fits in renal transplant recipients given cyclosporin A. Br Med J (Clin Res Ed) 1984;289:1347-1348
7. Atkinson K, Biggs J, Phil D, et al. Cyclosporine-associated central-nervous-system toxicity after allogeneic bone-marrow transplantation. N Engl J Med 1984;38:527
8. ↵
   Kahan BD, Wideman CA, Flechner S, Van Buren CT. Anaphylactic reaction to intravenous cyclosporin. Lancet 1984;1:52
9. ↵
   Thompson CB, June CH, Sullivan KM, Thomas ED. Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet 1984;2:1116-1120

   PubMedWeb of Science
10. Powell-Jackson PR, Carmichael FJ, Calne RY, Williams R. Adult respiratory distress syndrome and convulsions associated with administration of cyclosporine in liver transplant recipients. Transplantation 1984;38:341-343

    PubMedWeb of Science
11. Wilczek H, Ringden O, Tyden G. Cyclosporine-associated central nervous system toxicity after renal transplantation. Transplantation 1985;39:110

    CrossRefPubMed
12. Atkinson K, Biggs J, Darveniza P, Boland J, Concannon A, Dodds A. Cyclosporine-associated central nervous system toxicity after allogeneic bone marrow transplantation. Transplantation 1984;38:34-37

    PubMed
13. ↵
    Sloane JP, Lwin KY, Gore ME, Powles RL, Smith JF. Disturbance of blood-brain barrier after bone-marrow transplantation. Lancet 1985:280–281
14. Velu T, Debusscher L, Stryckmans PA. Cyclosporin-associated fatal convulsions. Lancet 1985;1:219
15. Beaman M, Parvin S, Veitch PS, Walls J. Convulsions associated with cyclosporin A in renal transplant recipients. Br Med J (Clin Res Ed) 1985;290:139-140
16. Berden JH, Hoitsma AJ, Merx JL, Keyser A. Severe central-nervous-system toxicity associated with cyclosporin. Lancet 1985;1:219-220
17. ↵
    Rubin AM, Kang H. Cerebral blindness and encephalopathy with cyclosporin A toxicity. Neurology 1987;37:1072-1076

    Abstract/FREE Full Text
18. ↵
    de Groen PC, Aksamit AJ, Rakela J, Forbes GS, Krom RA. Central nervous system toxicity after liver transplantation: the role of cyclosporin and cholesterol. N Engl J Med 1987;317:861-866

    PubMedWeb of Science
19. Bhatt BD, Meriano FV, Buchwald D. Cyclosporine-associated central nervous system toxicity. N Engl J Med 1988;318:788-789

    PubMed
20. Hoefnagels WA, Gerritsen EJ, Brouwer OF, Souverijn JH. Cyclosporin encephalopathy associated with fat embolism induced by the drug's solvent. Lancet 1988;2:901
21. Wilson SE, de Groen PC, Aksamit AJ, Wiesner RH, Garrity JA, Krom RAF. Cyclosporin A-induced reversible cortical blindness. J Clin Neuroophthalmol 1988;8:215-220

    PubMed
22. Lane RJ, Roche SW, Leung AA, Greco A, Lange LS. Cyclosporin neurotoxicity in cardiac transplant recipients. J Neurol Neurosurg Psychiatry 1988;51:1434-1437

    Abstract/FREE Full Text
23. ↵
    Scheinman SJ, Reinitz ER, Petro G, Schwartz RA, Szmalc FS. Cyclosporine central neurotoxicity following renal transplantation: report of a case using magnetic resonance images. Transplantation 1990;49:215-216

    PubMed
24. Lucey MR, Kolars JC, Merion RM, Campbell DA, Aldrich M, Watkins PB. Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA. Lancet 1990;335:11-15

    CrossRefPubMedWeb of Science
25. ↵
    Ghalie R, Fitzsimmons WE, Bennett D, Kaizer H. Cortical blindness: a rare complication of cyclosporine therapy. Bone Marrow Transplant 1990;6:147-149

    PubMedWeb of Science
26. Lloveras JJ, Larrue V, Suc E, Fourtanier G, Durand D. Leukoencephalopathy after cyclosporine in a liver transplant. Clin Transplantation 1990;4:58-62
27. Reece DE, Frei-Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991;8:393-401

    PubMedWeb of Science
28. ↵
    Truwit CL, Denaro CP, Lake JR, DeMarco T. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651-659

    Abstract/FREE Full Text
29. ↵
    Nussbaum ES, Maxwell RE, Bitterman PB, Hertz MI, Bula W, Latchaw RE. Cyclosporine A toxicity presenting with acute cerebellar edema and brainstem compression. J Neurosurg 1995;82:1068-1070

    PubMedWeb of Science
30. ↵
    Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165:627-631

    CrossRefPubMedWeb of Science
31. ↵
    Bartynski WS, Grabb BC, Zeigler Z, Lin L, Andrews DF. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr 1997;21:872-880

    CrossRefPubMed
32. Jansen O, Krieger D, Krieger S, Sartor K. Cortical hyperintensity on proton density-weighted images: an MR sign of cyclosporine-related encephalopathy. AJNR Am J Neuroradiol 1996;17:337-344

    Abstract
33. ↵
    Zimmer WE, Hourihane JM, Wang HZ, Schriber JR. The effect of human leukocyte antigen disparity on cyclosporin neurotoxicity after allogeneic bone marrow transplantation. AJNR Am J Neuroradiol 1998;19:601-608

    Abstract
34. ↵
    Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500

    CrossRefPubMedWeb of Science
35. Ito Y, Arahata Y, Goto Y, et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 1998;19:415-417

    Abstract
36. ↵
    Osborne A. Infection, white matter, abnormalities, and degenerative diseases (part 4). In: Osborne AG, ed. Diagnostic Neuroradiology. St. Louis, Mo: Mosby–Year Book ; 1994;764–766
37. ↵
    Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest 1986;55:455-462

    PubMedWeb of Science
38. Wijdicks EFM. Neurologic manifestations of immunosuppressive agents. In: Wijdicks EFM, ed. Neurologic Complications in Organ Transplant Recipients. Boston, Ma: Butterworth-Heinemann; 1999;127–140
39. ↵
    Holler E, Kolb HJ, Hiller E, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989;73:2018-2024

    Abstract/FREE Full Text
40. Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990;323:693-699

    CrossRefPubMedWeb of Science
41. ↵
    Mark AL. Cyclosporine, sympathetic activity, and hypertension. N Engl J Med 1990;323:748-750

    PubMedWeb of Science
42. ↵
    Zeigler ZR, Shadduck RK, Nemunaitis J, Andrews DF, Rosenfeld CS. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 1995;15:247-253

    PubMedWeb of Science
43. ↵
    Silva VA, Frei-Lahr D, Brown RA, Herzig GP. Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation. J Clin Apheresis 1991;6:16-20

    CrossRefPubMed
44. Carlson K, Smedmyr B, Hagberg H, Oberg G, Simonsson B. Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, Ara C, cyclophosphamide) ± TBI and autologous BMT for malignant lymphomas. Bone Marrow Transplant 1993;11:205-208

    PubMed
45. ↵
    Jones RJ, Lee KS, Beschorner WE, et al. Venocclusive disease of the liver following bone marrow transplantation. Transplantation 1987;44:778-783

    PubMedWeb of Science
46. ↵
    Zeigler ZR, Rosenfeld CS, Andrews DF III, et al. Plasma von Willebrand factor antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura/hemolytic uremic syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM). Am J Hematol 1996;53:213-220

    CrossRefPubMedWeb of Science
47. Mihatsch MJ, Thiel G, Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 1988;20:759-771

    PubMedWeb of Science
48. Remuzzi G, Bertani T. Renal vascular and thrombotic effects of cyclosporine. Am J Kidney Dis 1989;13:261-272

    PubMedWeb of Science
49. Kon V, Sugiura M, Inagami T, Harvie BR, Ichikawa I, Hoover RL. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990;37:1487-1491

    PubMedWeb of Science
50. ↵
    Pulsinelli WA, Jacewicz M. Animal models of brain ischemia. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. Stroke—Pathology, Diagnosis, and Management 2nd ed. New York, NY: Churchill Livingstone; 1992;50
51. ↵
    Ito T, Sakai T, Inagawa S, Utsu M, Bun T. MR angiography of cerebral vasospasm in preeclampsia. AJNR Am J Neuroradiol 1995;16:1344-1346

    Abstract
52. Sengar AR, Gupta RK, Dhanuka AK, Roy R, Das K. MR imaging, MR angiography, and MR spectroscopy of the brain in eclampsia. AJNR Am J Neuroradiol 1997;18:1485-1490

    Abstract
53. ↵
    Schaefer PW, Buonanno FS, Gonzalez RG, Schwamm LH. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997;28:1082-1085

    Abstract/FREE Full Text
54. Sabbatini M, Esposito C, Uccello F, et al. Acute effects of cyclosporine on glomerular dynamics—micropuncture study in the rat. Transplant Proc 1988;20:544-548

    PubMedWeb of Science
55. Smeesters C, Chaland P, Giroux L, et al. Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor. Transplant Proc 1988;20:663-669
56. Conte G, Sabbatini M, Napodano P, et al. Dopamine counteracts the acute renal effects of cyclosporine in normal subjects. Transplant Proc 1988;20:563-567

    PubMed
57. English J, Evan A, Houghton DC, Bennett WM. Cyclosporine-induced acute renal dysfunction in the rat: evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation 1987;44:135-141

    PubMedWeb of Science
58. ↵
    Dillon W, Brant-Zawadzki M, Sherry RG. Transient computed tomographic abnormalities after focal seizures. AJNR Am J Neuroradiol 1984;5:107-109

    FREE Full Text
59. Clarke HB, Gabrielsen TO. Seizure induced disruption of blood-brain barrier demonstrated by CT. J Comput Assist Tomogr 1989;13:889-892

    PubMedWeb of Science
60. Yaffe K, Ferriero D, Barkovich AJ, Rowley H. Reversible MRI abnormalities following seizures. Neuroradiology 1995;45:104-108
61. Warach S, Levin JM, Schomer DL, Holman BL, Edelman RR. Hyperperfusion of ictal seizure focus demonstrated by MR perfusion imaging. AJNR Am J Neuroradiol 1994;15:965-968

    Abstract/FREE Full Text
62. ↵
    Sperling MR. Neuroimaging in epilepsy: recent developments in MR imaging, positron-emission tomography, and single-photon emission tomography. Neurol Clin 1993;11:883-903

    PubMedWeb of Science